Coverage of Global Pharma Industry News
Merck has bagged the European Commission approval for the combination of its anti-PD-1 cancer immunotherapy Keytruda (pembrolizumab) with Lilly’s chemotherapy
Continue reading
Irish biopharma company Alkermes said that it has expanded an ongoing phase 1 trial for its immuno oncology drug ALKS
Continue reading
Novartis to acquire US biopharma company Endocyte for $2.1bn
Quotient Sciences opens formulation, manufacturing facility in US near Philadelphia
BMS’ Opdivo flops in CheckMate -331 trial in small cell lung cancer
Synspira’s cystic fibrosis treatment PAAG15A gets FDA orphan designation
MaaT Pharma doses first patient in HERACLES phase 2 trial of MaaT013
BMS, Compugen to trial COM701 Opdivo combo in advanced solid tumors
Eyevance bags global rights of ophthalmic drug Nexagon from OcuNexus
GNI Group to stop patient enrolment in F351 phase 2 liver fibrosis trial
FDA approves new dosing option for Amgen blood cancer drug Kyprolis
Five Prime, Zai Lab initiate phase 3 trial of bemarituzumab chemo combo
Business News Today
